Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
Money, if you get access to the document, it shows last month 2 of the non dilutive grant tranches were received totalling approx €1.1m. I’m assuming that it’s so buried in the annual report, that the market won’t yet catch on, so if they reinstate us, with the recent dilution, it’s a great opportunity for us to fill our boots as cash runway is covered for the next 12 months.
I have just under 1% of the company float, so dare not dream about a buy out. I know the directors would not consider any petty sums for a takeover, especially with their current cash position, ability to attract European Union backed non dilutive grants, 2 patents pending, 4 core programmes in development, overarching protection from other awarded patents and billion dollar deals being agreed for early stage pharma companies.
I’m going to try remain hopeful but realistic that it’s just a due diligence exercise and good conduct on behalf of the company, or I might make myself sick with shock.
This article today alone, shows anything biopharma is hot stuff, with companies being snapped up for £billions.
https://www.biospace.com/article/biospace-mergers-and-acquisitions-tracker/
Would be nice to see some juicy news from Eric and the team, especially following todays bumper bonanza!
He did say Q2 was when he expected things to get moving, so I’m expecting a news fresh period :)
Yes great opportunity for those who got in at the bottom as I personally doubt we’ll see those numbers again. Also nice to see new faces and some diamond hands. There is a telegram group that it would be great if you joined, just go on Twitter, search #genf and you’ll find the link there :)
Seems Eli Lilly are busy buying up readily established production plants for self administration injectables.
I would like to see SIRT6 being manufactured and available to the public to help boost their longevity via self injectables. It seems there are a diverse range of health benefits, not just for the liver!
https://www.biopharmadive.com/news/eli-lilly-nexus-manufacturing-factory-acquire/713897/